EUVIMEDEUVIMED entdecken
Crossref

Fluorescence-Guided Nanobomb for Triple-Action Tumor Annihilation Based on Fe/Mn Porphyrin MOFs

Aiai Wang, Hui Xu, Zhihui Xin, Yaru Li iD, Rong Wang, Xiaoliang Chen, Lu Zhao, Yunfeng Bai iD, Feng Feng iD

Molecular Pharmaceutics · 03.08.2026 · 23 (8) · 4227-4239

DOI: 10.1021/acs.molpharmaceut.6c00313 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 22.07.2026. Verfasst von Aiai Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Shanxi Provincial Key Laboratory of Chemical Biosensing, Shanxi Datong University, Datong037009, China. Hauptthemen laut MEDLINE: Porphyrins, Metal-Organic Frameworks. Die Arbeit nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Porphyrin bimetallic metal–organic frameworks (BMOFs) have promising applications in photodynamic therapy (PDT) and chemodynamic therapy (CDT) for tumor therapy. However, their therapeutic effect is restricted by the insufficient reactive oxygen species generated by BMOFs. Herein, a nanobomb, Fe-TCPP(Mn)/DOX/PEG/Apt-M (FTMDPA), with pH-responsive properties, was designed for fluorescence imaging-guided triple-action tumor annihilation. First, a novel Fe/Mn porphyrin BMOF, Fe-TCPP(Mn) (FTM), was assembled by a solvothermal method to achieve enhanced tumor therapy through ROS amplification. Under 660 nm laser irradiation, TCPP(Mn) could act as a photosensitizer to activate PDT. Significantly, TCPP(Mn) and Fe3+ exhibit peroxidase-like and Fenton-like activities, catalyzing the generation of •OH from H2O2, which effectively amplifies CDT. Besides, FTMDPA exhibits pH-responsive DOX release capability, which could achieve chemotherapy (CHT), and could efficiently accumulate at the tumor site with the aid of an aptamer. Importantly, FTMDPA exhibits fluorescence imaging, which has potential applications in detection and image-guided precision therapy. Therefore, the designed nanobomb integrates targeted delivery, pH responsiveness, fluorescence imaging, and amplified PDT-CDT-CHT triple-action tumor annihilation into a single system, providing a promising strategy for tumor diagnosis and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PorphyrinsMetal-Organic FrameworksPhotochemotherapyHumansAnimalsIronDoxorubicinPhotosensitizing AgentsManganeseMiceReactive Oxygen SpeciesCell Line, TumorHydrogen-Ion ConcentrationOptical ImagingHydrogen Peroxide

Stichwörter der Autor:innen

AptamerBimetallic metal−organic frameworksFenton-likeNanobombPeroxidase-like

Substanzen

PorphyrinsMetal-Organic FrameworksIronDoxorubicinPhotosensitizing AgentsManganeseReactive Oxygen SpeciesHydrogen Peroxide

Autor:innen und Institutionen

  • School of Chemistry and Chemical Engineering, Shanxi Provincial Key Laboratory of Chemical Biosensing, Shanxi Datong University, Datong037009, China.
  • School of Agriculture and Life Science, Shanxi Datong University, Datong037009, China.
  • School of Medical, Shanxi Datong University, Datong037009, China.

ORCID-Profile: Yaru Li, Yunfeng Bai, Feng Feng

Zitieren

APA

Wang, A., Xu, H., Xin, Z., Li, Y., Wang, R., Chen, X., Zhao, L., Bai, Y., & Feng, F. (2026). Fluorescence-Guided Nanobomb for Triple-Action Tumor Annihilation Based on Fe/Mn Porphyrin MOFs. Molecular Pharmaceutics, 23(8), 4227-4239. https://doi.org/10.1021/acs.molpharmaceut.6c00313

Vancouver

Wang A, Xu H, Xin Z, Li Y, Wang R, Chen X, et al. Fluorescence-Guided Nanobomb for Triple-Action Tumor Annihilation Based on Fe/Mn Porphyrin MOFs. Molecular Pharmaceutics. 2026;23(8):4227-4239. doi:10.1021/acs.molpharmaceut.6c00313

BibTeX
@article{Wang2026,
  author = {Wang, Aiai and Xu, Hui and Xin, Zhihui and Li, Yaru and Wang, Rong and Chen, Xiaoliang and Zhao, Lu and Bai, Yunfeng and Feng, Feng},
  title = {Fluorescence-Guided Nanobomb for Triple-Action Tumor Annihilation Based on Fe/Mn Porphyrin MOFs},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {8},
  pages = {4227--4239},
  doi = {10.1021/acs.molpharmaceut.6c00313}
}
Kostenlos starten →